<?xml version='1.0' encoding='utf-8'?>
<document id="27640752"><sentence text="Virtual Clinical Trial Toward Polytherapy Safety Assessment: Combination of Physiologically Based Pharmacokinetic/Pharmacodynamic-Based Modeling and Simulation Approach With Drug-Drug Interactions Involving Terfenadine as an Example."><entity charOffset="207-218" id="DDI-PubMed.27640752.s1.e0" text="Terfenadine" /></sentence><sentence text="A Quantitative Systems Pharmacology approach was utilized to predict the cardiac consequences of drug-drug interaction (DDI) at the population level" /><sentence text=" The Simcyp in vitro-in vivo correlation and physiologically based pharmacokinetic platform was used to predict the pharmacokinetic profile of terfenadine following co-administration of the drug"><entity charOffset="143-154" id="DDI-PubMed.27640752.s3.e0" text="terfenadine" /></sentence><sentence text=" Electrophysiological effects were simulated using the Cardiac Safety Simulator" /><sentence text=" The modulation of ion channel activity was dependent on the inhibitory potential of drugs on the main cardiac ion channels and a simulated free heart tissue concentration" /><sentence text=" ten Tusscher's human ventricular cardiomyocyte model was used to simulate the pseudo-ECG traces and further predict the pharmacodynamic consequences of DDI" /><sentence text=" Consistent with clinical observations, predicted plasma concentration profiles of terfenadine show considerable intra-subject variability with recorded Cmax values below 5 ng/mL for most virtual subjects"><entity charOffset="83-94" id="DDI-PubMed.27640752.s7.e0" text="terfenadine" /></sentence><sentence text=" The pharmacokinetic and pharmacodynamic effects of inhibitors were predicted with reasonable accuracy" /><sentence text=" In all cases, a combination of the physiologically based pharmacokinetic and physiology-based pharmacodynamic models was able to differentiate between the terfenadine alone and terfenadine + inhibitor scenario"><entity charOffset="156-167" id="DDI-PubMed.27640752.s9.e0" text="terfenadine" /></sentence><sentence text=" The range of QT prolongation was comparable in the clinical and virtual studies" /><sentence text=" The results indicate that mechanistic in vitro-in vivo correlation can be applied to predict the clinical effects of DDI even without comprehensive knowledge on all mechanisms contributing to the interaction" /><sentence text="" /></document>